+ 0.00
+ 0%
+ -0.01
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%

Why Teledoc Health's Stock Is Trading Higher Today

June 15, 2020 1:35 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Why Teledoc Health's Stock Is Trading Higher Today

Teladoc Health (NYSE:TDOC) shares are trading higher amid a rebound in coronavirus cases. The coronavirus pandemic has been a positive catalyst for telemedicine.

As states begin to reopen, uncertainty around telemedicine’s demand is increasing amongst investors. The spike in coronavirus cases could potentially decrease that uncertainty as some states may tighten restrictions again to tackle the spread of COVID-19.

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. Its platform connects members with a network of physicians and behavioral health professionals.

Teladoc Health was trading 7.96% higher at $185.70 at time of publication on Monday. The stock has a 52-week high of $203.85 and a 52-week low of $54.58.


Movers Trading Ideas

Related Articles

Why Teladoc Health, Arcturus And Meridian Are Moving Today

Arcturus Therapeutics (NASDAQ: ARCT) shares are trading higher on Thursday after Wells Fargo initiated coverage on the stock with an Overweight rating. read more

Why BioCryst, VistaGen And Teladoc Are Moving Today

VistaGen Therapeutics (NASDAQ: VTGN) shares are trading higher after Maxim raised its price target on the stock from $3 to $5. read more

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Biolase (NASDAQ:BIOL) stock rose 17.3% to $1.22 during Friday's after-market session. Trading volume for this security closed at 1.7 million, accounting for 7.15% of its average full-day volume over the last 100 days. The company's market cap stands at $114.0 million. read more

Teladoc Shares Quiet Following After-Hours Industry Report From CNBC 'Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million'

https://www.cnbc.com/2021/01/14/healthtech-firm-accolade-is-buying-telemedicine-start-up-2ndmd-for-460-million-sources-say.html?utm_term=Autofeed&utm_medium=Social&utm_content=Main&utm_source=Twitter#Echobox= read more